Atlas Trials

Albumin-Bound Paclitaxel Combined With Carboplatin as Neoadjuvant Chemotherapy in Luminal B/HER-2 Negative Breast Cancer

Clinical trial NCT03799692 · UNKNOWN

Trial details

NCT number
NCT03799692
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HER-2 Negative Breast Cancer
Start date
2018-11-19
Primary completion
2019-03-30
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.